DoW Peer Reviewed Medical, Research Advancement Award

HT942526PRMRPRAA · Defense Health Agency Contracting Activity - DHACA

biomedical clinical public health mental behavioral health education workforce Science & Technology R&D

Closes: 2026-07-30 · 23 d
Award ceiling: —
Award floor: —
Program funding: $19,600,000
Expected awards: 14
Cost sharing: No
Posted: 2026-05-08
Instrument: Cooperative Agreement, Grant

Characterization · gpt-5.4-mini · 2026-07-07

Supports fundamental, use-inspired research with preliminary data on FY26 PRMRP topic areas and strategic goals, funded to eligible applicants through a CDMRP Research Advancement Award.

Funds: basic research
University: direct
social behavioral: minor
physical sciences: minor
engineering: minor
life biomedical: central
computational data: minor

⚑ Requires preliminary data · FY26 PRMRP topic areas and portfolio-specific strategic goals only · Maximum period of performance 4 years · Total cost cap $1.4M per award; roughly 14 awards expected

Unit fits — one characterization, each unit's own rules

IPPRA	58 good	portfolio topics: public_health, mental_behavioral_health; social/behavioral work is minor; funds basic research; clinical-trial/biomedical core — IPPRA angle is policy/community (capped)
Physical Sciences & Engineering (demo)	55 good	technical depth: minor; funds basic research
Tom Love Innovation Hub	15 none	deep-tech content; no commercialization signal

Description

Summary: The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Research Advancement Award supports fundamental research studies that will make an important contribution towards research, patient care, and/or quality of life for a disease or condition related to one of the congressionally directed FY26 PRMRP topic areas and one of the FY26 PRMRP portfolio-specific strategic goals.

Distinctive Features: Applications must include preliminary data. The Research Advancement Award supports use-inspired basic research to further or validate preliminary findings for short- and long-term impact. Proposed research projects may range from hypothesis testing to expansion of mature data.

Funding Details: The Congressionally Directed Medical Research Programs (CDMRP) expects to allot roughly $19.6M to fund approximately 14 Research Advancement Award applications with total cost caps of $1.4M per award. The maximum period of performance is 4 years. It is anticipated that awards made from this FY26 funding opportunity will be funded with FY26 funds, which will expire for use on September 30, 2032. Awards supported with FY26 funds will be made no later than September 30, 2027.

Apply

View on Grants.gov → CONTACT: Christopher L Baker Grants Officer <help@eBRAP.org>

IPPRA / Grant Monitor